USANA Health Sciences Inc (USNA) stock
Close on Nov 12, 2026Market cap $235.21MP/E –Yield –
USANA Health Sciences Inc saw revenue fall 0.8% to $905.58M over the twelve months to Oct 3, 2026. Operating income fell 109.0% to -$3.75M, moving the operating margin from 4.6% to -0.4%. Free cash flow was $29.54M, up 58.0% from a year earlier. At the latest close the market valued the company at $235.21M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Oct 3, 2026
Valuation
- Market cap
- $235.21M
- P/E ratio
- –
- Price to sales
- 0.26
- Price to book
- 0.45
- Dividend yield
- –
- Free cash flow yield
- 12.56%
Fundamentals
- Revenue
- $905.58M
- Net income
- -$21.20M
- EPS, diluted
- -$1.15
- Free cash flow
- $29.54M
- Book value per share
- $28.48
- Diluted shares
- 18M
Trading
- Next earnings
- Feb 17, 2027 (estimated, after the close)
- Previous close
- $12.85
- Open
- $12.89
- Day's range
- $12.53 – $12.95
- Volume
- 201,594
- Average volume (20 days)
- 203,581
- Index membership
- Russell 2000, Russell 3000
- Beta (5 years)
- 0.65
- 52-week range
- $12.57 – $23.59
- RSI (14 days)
- 32.9
- Volatility (1 year)
- 53.3%
- Relative volume
- 1.00×
- WACC
- 8.1%
On 1 of our idea list: More cash than they're worth
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2010, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | USNA | S&P 500 | Difference | USNA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -14.8% | -2.7% | −12.2 pts | ||
| 3 months | -6.0% | -1.7% | −4.2 pts | ||
| Year to date | -35.2% | +11.9% | −47.0 pts | ||
| 1 year | -34.3% | +12.0% | −46.3 pts | ||
| 3 years | -71.9% | +78.2% | −150.1 pts | -34.5% | +21.2% |
| 5 years | -87.4% | +73.2% | −160.6 pts | -33.9% | +11.6% |
| 10 years | -79.9% | +309.6% | −389.6 pts | -14.8% | +15.1% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases USANA Health Sciences filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
About USANA Health Sciences
Medicinal Chemicals & Botanical Products
USANA Health Sciences, Inc. develops and manufactures nutritional supplements, functional foods, and personal care products. The company organizes its operations into two reportable segments: Core nutritional and Hiya direct-to-consumer. Its offerings include targeted supplements, core vitamin and mineral supplements, meal replacement shakes, snack bars, skincare lines, and children's wellness items like chewable multivitamins and probiotics. Core nutritional products serve Brand Partners—who act as independent distributors and purchase for personal use—and Preferred Customers, who buy solely for personal consumption. Hiya serves retail consumers directly, primarily through a subscription model.
Company profile, executives and historyUSANA Health Sciences stock: common questions
What is USANA Health Sciences's stock price?
USNA closed at $12.73 on Nov 12, 2026, down 0.93% on the day. Over the past 52 weeks it traded between $12.57 and $23.59.
What is USANA Health Sciences's market cap?
USANA Health Sciences was worth $235.21M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is USNA's P/E ratio?
USANA Health Sciences lost money over the twelve months to Oct 3, 2026 (diluted EPS -$1.15), so it has no meaningful P/E ratio.
How much revenue does USANA Health Sciences make?
USANA Health Sciences reported revenue of $905.58M for the twelve months to Oct 3, 2026, down 0.8% from a year earlier.
Does USANA Health Sciences pay a dividend?
No. USANA Health Sciences has not paid a cash dividend over the last twelve months.
When does USANA Health Sciences report earnings next?
USANA Health Sciences is expected to report Q4 FY2026 results on Feb 17, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has USNA stock performed over the past year?
Including dividends, USNA returned -34.3% over the past year, against +12.0% for the S&P 500.
How many USNA shares are sold short?
1M shares were sold short at the latest FINRA report, 8.06% of the float, or 5.2 days of average trading volume.
Who are USANA Health Sciences's competitors?
Companies most similar to USANA Health Sciences by business, industry and size include NATR, TLRY, MTEX, CRLBF, PBH.
See a number that looks wrong?